Xanthi Coskinas

Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer

Ian D. Davis, Andrew Martin, Martin R. Stockler et al. · New England Journal of Medicine · 2019 · 1.6K citations

Pharmacy, Oncology, Pharmacotherapy +17

Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP

Martin R. Stockler, Andrew Martin, Ian D. Davis et al. · Journal of Clinical Oncology · 2021 · 60 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Overall Survival of Men with Metachronous Metastatic Hormone-sensitive Prostate Cancer Treated with Enzalutamide and Androgen Deprivation Therapy

Christopher J. Sweeney, Andrew Martin, Martin R. Stockler et al. · European Urology · 2021 · 48 citations

Medicine, Oncology, Urology +14

A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial

Andrew R. Davidson, A.-S. Veillard, Annette Tognela et al. · Annals of Oncology · 2015 · 33 citations

Medicine, Oncology, Pharmacology +13

Comparing patients’ and clinicians’ assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial)

Michaella Jayne Smith, P. Grantley Gill, Neil Wetzig et al. · Breast Cancer Research and Treatment · 2008 · 19 citations

Medicine, Oncology, Surgery +16